Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 10

1590P - Prevalence and impact on survival of presentation to the emergency room of cancer patients: A retrospective study on real-life data

Date

14 Sep 2024

Session

Poster session 10

Topics

Statistics;  Cancer Epidemiology;  Cancer Diagnostics

Tumour Site

Presenters

Sonia Priou

Citation

Annals of Oncology (2024) 35 (suppl_2): S937-S961. 10.1016/annonc/annonc1606

Authors

S. Priou1, M. Barclay2, A. Cohen3, M. Verdoux3, R. Flicoteaux4, A. Laurent5, G. Chatellier6, C. Tournigand7, G. Lyratzopoulos8, E. Kempf7, G. Lamé1

Author affiliations

  • 1 Laboratoire Génie Industriel, CentraleSupélec - Paris-Saclay campus, 91192 - Gif sur Yvette/FR
  • 2 Epidemiology Of Cancer Healthcare And Outcomes, Research Department Of Behavioural Science And Health, Institute Of Epidemiology And Health Care, UCL - University College London, WC1E 6BT - London/GB
  • 3 Innovation And Data, It Department,, Assistance Publique - Hopitaux De Paris, 75012 - Paris/FR
  • 4 Department Of Medical Information, Assistance Publique - Hopitaux De Paris, 75012 - Paris/FR
  • 5 Department Of Digestive Surgery,, Centre Hospitalier Universitaire Henri-Mondor AP-HP, 94010 - Creteil/FR
  • 6 Department Of Medical Informatics, Assistance Publique - Hopitaux De Paris, 75012 - Paris/FR
  • 7 Department Of Medical Oncology, Centre Hospitalier Universitaire Henri-Mondor AP-HP, 94010 - Creteil/FR
  • 8 Epidemiology, Public Health, University College London Hospital - University College London Hospitals NHS Foundation Trust, NW1 2BU - London/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1590P

Background

International studies have highlighted the poor outcomes associated with cancer diagnosis following an emergency presentation (EP) to hospital. This study aims at assessing the rate of cancer patients newly referred to the Greater Paris University Hospitals (APHP) after an EP and the impact of EP on patient survival across various types of cancer.

Methods

A retrospective multicenter cohort study was conducted using the data warehouse of APHP. Consecutive patients newly referred with breast, lung, colon, rectum or pancreatic cancer between January 2019 and June 2022 were identified using claims data (ICD-10 codes). Comparative analyses between EP (diagnosis confirmed ≤30 days after emergency admission) and non-EP patients comprised in-hospital imaging, initial tumor staging from baseline PET/CT and CT-scan reports, and surgical treatment. Multivariable logistic regression was used to assess EP prevalence and its association with patient survival, adjusting for age, gender, diagnostic year (considering potential impacts of the COVID-19 pandemic), and cancer site. A Cox model was used to assess association of EP with survival, adjusting for the same factors and baseline metastatic status.

Results

The final cohort comprised 25,845 patients with 3,960 (15.3%) newly referred after an EP. EP patients exhibited higher rates of metastatic cancer (59% vs. 45%) and in-hospital imaging (53% vs. 31%), lower surgery rates (except for colon cancer patients) (18% vs 41%), and a higher risk to die within a year of diagnosis (49% vs 16%). Lung and pancreatic cancers were more frequent in EP than other cancer sites (20% and 23% respectively). The proportion of EP and non-EP patients was comparable during and after the COVID-19 pandemic, except for lung cancer. In the multivariable analysis, EP was strongly associated with age only for patients above 80 years of age (odds ratio: 3.1, 95% CI; 2.6-3.6). After adjusting for age and cancer site, patient mortality rate increased with EP referral (HR: 2.7, 95% CI 2.5-2.8).

Conclusions

Emergency presentation in a university hospital is a marker of poor outcome among newly referred cancer patients. Better coordination between hospitals and ambulatory health care networks is needed.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.